Gliclazide (Gliclazide)



Combined with:

Indications and Reactions:

Role Indications Reactions
Primary
Type 2 Diabetes Mellitus 68.8%
Diabetes Mellitus Non-insulin-dependent 12.5%
Diabetes Mellitus 6.3%
Diabetes Mellitus Inadequate Control 6.3%
Drug Use For Unknown Indication 6.3%
Hypoglycaemia 28.6%
Respiratory Failure 28.6%
Hyperphagia 14.3%
Obesity 14.3%
Tinnitus 14.3%
Secondary
Product Used For Unknown Indication 27.2%
Drug Use For Unknown Indication 25.8%
Diabetes Mellitus 17.4%
Type 2 Diabetes Mellitus 8.0%
Angina Pectoris 5.6%
Schizophrenia, Paranoid Type 4.7%
Hypertension 2.3%
Gout 1.9%
Cardiac Disorder 0.9%
Depression 0.9%
Dyslipidaemia 0.9%
Essential Hypertension 0.9%
Blood Cholesterol Increased 0.5%
Cardiac Failure 0.5%
Diabetes Mellitus Non-insulin-dependent 0.5%
Hypoglycaemia 0.5%
Ill-defined Disorder 0.5%
Lower Respiratory Tract Infection 0.5%
Osteoarthritis 0.5%
Hypoglycaemia 17.9%
Sleep Terror 10.3%
Vomiting 10.3%
Weight Decreased 10.3%
Obesity 7.7%
Melaena 5.1%
Renal Failure Acute 5.1%
Coma 2.6%
Erythema 2.6%
Hypertriglyceridaemia 2.6%
Hypophagia 2.6%
Idiopathic Pulmonary Fibrosis 2.6%
Jaundice 2.6%
Lower Respiratory Tract Infection 2.6%
Malaise 2.6%
Malignant Melanoma 2.6%
Metabolic Disorder 2.6%
Monoparesis 2.6%
Nausea 2.6%
Pancreatitis 2.6%
Concomitant
Product Used For Unknown Indication 27.8%
Diabetes Mellitus 14.3%
Depression 7.5%
Type 2 Diabetes Mellitus 6.2%
Blood Cholesterol Increased 5.7%
Hypertension 5.2%
Vascular Dementia 4.4%
Drug Use For Unknown Indication 3.6%
Lower Respiratory Tract Infection 2.9%
Diabetes Mellitus Non-insulin-dependent 2.6%
Hypercholesterolaemia 2.6%
Schizophrenia 2.3%
Blood Glucose Increased 2.1%
Epilepsy 2.1%
Essential Thrombocythaemia 2.1%
Metastatic Renal Cell Carcinoma 2.1%
Hepatitis C 1.8%
Acute Myocardial Infarction 1.6%
Atrial Fibrillation 1.6%
Cerebrovascular Accident 1.6%
Weight Decreased 18.3%
Psychotic Disorder 6.9%
Vomiting 6.1%
Bladder Cancer 5.3%
Rhabdomyolysis 5.3%
Vision Blurred 5.3%
Pneumonia 4.6%
Renal Failure 4.6%
Renal Failure Acute 4.6%
Somnolence 4.6%
Sudden Death 4.6%
Pulmonary Oedema 3.8%
Thrombocytopenia 3.8%
White Blood Cell Count Decreased 3.8%
Diarrhoea 3.1%
Joint Swelling 3.1%
Liver Function Test Abnormal 3.1%
Metabolic Acidosis 3.1%
Pulmonary Embolism 3.1%
Pyrexia 3.1%